EUVIMEDEUVIMED entdecken
Metaanalyse

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Limited-Stage Small-Cell Lung Cancer: A Meta-Analysis

Shuang Zhang iD, Yansu Wang, Ying Cheng iD

Future Oncology · 2023

DOI: 10.2217/fon-2022-0523 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Future Oncology, 2023. Verfasst von Shuang Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun 130000, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Science and Technology Development Plan Project in Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in limited-stage small-cell lung cancer (LS-SCLC) remains controversial.

Methods

Using pooled hazard ratios (HR) with 95% CIs, we assessed the correlation of pre-treatment NLR and PLR with overall survival (OS) and progression-free survival (PFS) in LS-SCLC. Publication bias was assessed by Begg's and Egger's tests.

Results

Ten studies were enrolled in our meta-analysis. Pooled analyses showed that pre-treatment high NLR was significantly associated with poor OS (HR: 1.80) and PFS (HR: 1.69) in LS-SCLC patients. High pre-treatment PLR was also associated with shorter OS (HR: 1.52) and PFS (HR: 1.39) in LS-SCLC patients.

Conclusion

Our meta-analysis suggests that high pre-treatment NLR or PLR may be negatively related to OS and PFS in LS-SCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsSmall Cell Lung CarcinomaHumansBiomarkersLymphocytesNeutrophilsPrognosis

Stichwörter der Autor:innen

limited-stage small-cell lung cancermeta-analysisneutrophil-to-lymphocyte ratioplatelet-to-lymphocyte ratioprognostic markers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun 130000, China.
  • Clinical Research Big Data Center, Jilin Cancer Hospital, Changchun 130000, China.
  • Department of Thoracic Oncology, Jilin Cancer Hospital, 1066 Jinhu Rd, Changchun 130000, China.

ORCID-Profile: Shuang Zhang, Ying Cheng

Förderung

  • Science and Technology Development Plan Project in Jilin Province

Zitieren

APA

Zhang, S., Wang, Y., & Cheng, Y. (2023). Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Limited-Stage Small-Cell Lung Cancer: A Meta-Analysis. Future Oncology. https://doi.org/10.2217/fon-2022-0523

Vancouver

Zhang S, Wang Y, Cheng Y. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Limited-Stage Small-Cell Lung Cancer: A Meta-Analysis. Future Oncology. 2023. doi:10.2217/fon-2022-0523

BibTeX
@article{Zhang2023,
  author = {Zhang, Shuang and Wang, Yansu and Cheng, Ying},
  title = {Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Limited-Stage Small-Cell Lung Cancer: A Meta-Analysis},
  journal = {Future Oncology},
  year = {2023},
  doi = {10.2217/fon-2022-0523}
}
Kostenlos starten →